Levin has developed and tested vaccines for a variety of infections over several decades and said the recent progress is stunning. Innovations in vaccines are the direct result of global efforts to combat the COVID-19 pandemic. How to get more information: People who wish to be screened to participate my call 72 or send an email to.People ages 65 to 85 who do not have a history of heart disease are eligible for the Pfizer clinical trial. Who is eligible to participate: The new mRNA flu vaccines are being tested first on older adults.Where: University of Colorado Anschutz Medical Campus in Aurora.The Moderna clinical trial for a combined flu/COVID-19 vaccine will start later this summer or fall. When: The Pfizer clinical trial is expected to start in mid-August.What: Testing for new type of flu vaccines based on mRNA technology (like COVID-19 vaccines). ![]() “We’ll just need to confirm their safety and efficacy through the clinical trials,” he said.Ĭlinical trials launching for new mRNA flu vaccines While it’s too soon to know whether mRNA flu vaccines will work better than traditional flu jabs, Levin is confident that they will be as safe and effective as the COVID-19 vaccines. Moderna has created a new vaccine that aims to provide combined protection against both flu and COVID-19, including the most recent variants of COVID-19. In the coming weeks, Levin also expects to enroll volunteers for another clinical trial realted to mRNA flu vaccines. The Colorado site is one of about 25 across the country where Pfizer will be conducting early tests on a new mRNA flu vaccine. Patients at the UCHealth Seniors Clinic will be able to volunteer for the study, as will other older adults. Myron Levin, an expert on infectious diseases and vaccines, expects to enroll older adults for the first round of testing at the University of Colorado Anschutz Medical Campus. The first group of participants in Colorado - 50 people ages 65 to 85 - could start receiving mRNA flu vaccines as early as mid-August. The vaccines then train the immune system to prevent actual infections. These proteins don’t cause illness, but are the same type that we’d get during a COVID-19 or flu infection. These vaccines use messenger RNA (or mRNA) to “teach” cells to make proteins. COVID-19 vaccines, those made by Pfizer and Moderna. ![]() The new flu vaccines are based on mRNA technology, the same method that was used to create the most common and successful U.S. Source: Getty Images.Īn entirely new type of flu vaccine could better protect people from influenza, and clinical trials of the vaccines are starting this month. New flu vaccines, based on COVID vaccines, are being tested now. Entirely new mRNA flu vaccines could better fight many influenza strains.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |